Serious staphylococcal infections.
Backx
Matthijs
M
National Public Health Service Wales, University Hospital of Wales, Cardiff.
Healy
Brendan
B
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D017576:Daptomycin / Q000627:therapeutic use; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects; D008911:Minocycline / Q000031:analogs & derivatives / Q000627:therapeutic use; D023303:Oxazolidinones / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology; D013211:Staphylococcus aureus / Q000302:isolation & purification*; D000078304:Tigecycline; D020713:Vancomycin Resistance / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000078304:Tigecycline; D008911:Minocycline; D017576:Daptomycin